Concert Pharmaceuticals (CNCE) Holder Bvf Cut Its Holding as Stock Price Declined; Amazon Com (AMZN) Market Valuation Rose While Antipodean Advisors Has Boosted Holding

May 24, 2018 - By Peter Erickson

Amazon.com, Inc. (NASDAQ:AMZN) Logo

Bvf Inc decreased its stake in Concert Pharmaceuticals Inc (CNCE) by 37.17% based on its latest 2017Q4 regulatory filing with the SEC. Bvf Inc sold 1.17 million shares as the company’s stock declined 14.38% with the market. The hedge fund held 1.97M shares of the health care company at the end of 2017Q4, valued at $50.96 million, down from 3.14M at the end of the previous reported quarter. Bvf Inc who had been investing in Concert Pharmaceuticals Inc for a number of months, seems to be less bullish one the $472.83 million market cap company. The stock decreased 0.88% or $0.18 during the last trading session, reaching $20.21. About 81,508 shares traded. Concert Pharmaceuticals, Inc. (NASDAQ:CNCE) has risen 26.05% since May 24, 2017 and is uptrending. It has outperformed by 14.50% the S&P500.

Eric Chen increased its stake in Amazon Com Inc (AMZN) by 133.61% based on its latest 2017Q4 regulatory filing with the SEC. Antipodean Advisors Llc bought 7,950 shares as the company’s stock rose 28.13% while stock markets declined. The hedge fund run by Eric Chen held 13,900 shares of the consumer services company at the end of 2017Q4, valued at $16.26M, up from 5,950 at the end of the previous reported quarter. Antipodean Advisors Llc who had been investing in Amazon Com Inc for a number of months, seems to be bullish on the $777.27B market cap company. The stock increased 1.29% or $20.46 during the last trading session, reaching $1601.86. About 2.97M shares traded. Amazon.com, Inc. (NASDAQ:AMZN) has risen 76.78% since May 24, 2017 and is uptrending. It has outperformed by 65.23% the S&P500.

Since December 7, 2017, it had 0 buys, and 21 selling transactions for $64.49 million activity. 2,000 Amazon.com, Inc. (NASDAQ:AMZN) shares with value of $2.99M were sold by WILKE JEFFREY A. $18.50M worth of stock was sold by Blackburn Jeffrey M on Thursday, February 15. Reynolds Shelley sold 544 shares worth $795,502. 2,285 shares valued at $3.35 million were sold by ALBERG TOM A on Thursday, February 15. Jassy Andrew R had sold 1,985 shares worth $2.90M. Zapolsky David also sold $3.03 million worth of Amazon.com, Inc. (NASDAQ:AMZN) shares.

Among 55 analysts covering Amazon.com (NASDAQ:AMZN), 52 have Buy rating, 0 Sell and 3 Hold. Therefore 95% are positive. Amazon.com had 302 analyst reports since July 21, 2015 according to SRatingsIntel. Robert W. Baird maintained the shares of AMZN in report on Monday, September 11 with “Buy” rating. The firm earned “Buy” rating on Tuesday, April 10 by Piper Jaffray. The company was maintained on Monday, October 17 by Credit Suisse. The stock has “Buy” rating by Stifel Nicolaus on Monday, September 18. The stock of Amazon.com, Inc. (NASDAQ:AMZN) has “Hold” rating given on Friday, October 23 by Canaccord Genuity. KeyBanc Capital Markets maintained Amazon.com, Inc. (NASDAQ:AMZN) on Wednesday, June 21 with “Hold” rating. The firm earned “Buy” rating on Wednesday, October 11 by Piper Jaffray. The firm earned “Buy” rating on Friday, October 27 by UBS. Stifel Nicolaus maintained the shares of AMZN in report on Friday, February 2 with “Buy” rating. The rating was maintained by Piper Jaffray with “Buy” on Monday, June 12.

Investors sentiment increased to 1.29 in 2017 Q4. Its up 0.03, from 1.26 in 2017Q3. It improved, as 69 investors sold AMZN shares while 578 reduced holdings. 168 funds opened positions while 667 raised stakes. 280.02 million shares or 0.09% more from 279.77 million shares in 2017Q3 were reported. Meag Munich Ergo Kapitalanlagegesellschaft Mbh stated it has 28,414 shares or 1.31% of all its holdings. C V Starr And Inc reported 8.86% in Amazon.com, Inc. (NASDAQ:AMZN). Global X Mngmt Lc owns 3,225 shares. Tdam Usa has invested 0.08% in Amazon.com, Inc. (NASDAQ:AMZN). Highlander Capital Mgmt Ltd reported 975 shares. Savings Bank Of New York Mellon holds 1.25% or 4.07 million shares in its portfolio. Hilton Capital Management Ltd Liability Com reported 1.1% of its portfolio in Amazon.com, Inc. (NASDAQ:AMZN). Wetherby Asset Management Inc invested in 1.19% or 7,316 shares. National Pension Ser invested in 329,173 shares or 1.92% of the stock. Alliancebernstein LP reported 0.68% stake. Telemark Asset Management Ltd Liability reported 60,000 shares stake. Moreover, Torray Ltd Limited Liability Company has 0.05% invested in Amazon.com, Inc. (NASDAQ:AMZN). Columbia Asset Management, Michigan-based fund reported 4,473 shares. Harbour Investment Mgmt Limited Com accumulated 2.05% or 2,489 shares. Sii Invests Inc Wi accumulated 3,221 shares.

More notable recent Amazon.com, Inc. (NASDAQ:AMZN) news were published by: Investorplace.com which released: “20 Stocks Hedge Fund Managers Are Buying In Bulk” on May 23, 2018, also Seekingalpha.com with their article: “The Proof That Amazon Is Undervalued” published on May 23, 2018, Fool.com published: “What’s Up With All These Retailers Partnering With Amazon.com?” on May 22, 2018. More interesting news about Amazon.com, Inc. (NASDAQ:AMZN) were released by: Nasdaq.com and their article: “Amazon.com, Inc. (AMZN) Will Now Deliver to Your Car Trunk with Key In-Car” published on April 25, 2018 as well as Seekingalpha.com‘s news article titled: “Amazon’s Advertising Business: An Emerging Giant” with publication date: May 21, 2018.

Investors sentiment increased to 2.62 in 2017 Q4. Its up 1.44, from 1.18 in 2017Q3. It improved, as 10 investors sold CNCE shares while 19 reduced holdings. 42 funds opened positions while 34 raised stakes. 15.49 million shares or 6.32% more from 14.57 million shares in 2017Q3 were reported. Senzar Asset holds 276,345 shares or 1.83% of its portfolio. State Of New Jersey Common Pension Fund D holds 0% or 40,000 shares in its portfolio. Wells Fargo & Com Mn has invested 0% in Concert Pharmaceuticals, Inc. (NASDAQ:CNCE). Texas-based Bridgeway Capital Management has invested 0.05% in Concert Pharmaceuticals, Inc. (NASDAQ:CNCE). Driehaus Capital Mgmt Ltd Co holds 0.1% in Concert Pharmaceuticals, Inc. (NASDAQ:CNCE) or 100,000 shares. D E Shaw And, New York-based fund reported 103,417 shares. Qs Investors Ltd Liability Co, a New York-based fund reported 88,705 shares. Aureus Asset Llc holds 0.06% of its portfolio in Concert Pharmaceuticals, Inc. (NASDAQ:CNCE) for 15,625 shares. Connor Clark Lunn Mngmt Limited holds 99,525 shares or 0.02% of its portfolio. Goldman Sachs Gp Inc holds 0% in Concert Pharmaceuticals, Inc. (NASDAQ:CNCE) or 98,786 shares. 36,621 were accumulated by Schwab Charles Mgmt Inc. Wellington Grp Llp accumulated 0% or 21,540 shares. Her Majesty The Queen In Right Of The Province Of Alberta As Represented By Alberta Investment Corp holds 0% or 12,700 shares in its portfolio. California State Teachers Retirement stated it has 28,249 shares or 0% of all its holdings. Lyon Street Llc, a California-based fund reported 204,077 shares.

Bvf Inc, which manages about $999.89M and $829.55 million US Long portfolio, upped its stake in Forward Pharma A/S by 2.00M shares to 3.46M shares, valued at $12.65M in 2017Q4, according to the filing. It also increased its holding in Arqule Inc (NASDAQ:ARQL) by 9.04M shares in the quarter, for a total of 16.44 million shares, and has risen its stake in Regulus Therapeutics Inc (NASDAQ:RGLS).

Analysts await Concert Pharmaceuticals, Inc. (NASDAQ:CNCE) to report earnings on August, 14. They expect $-0.62 EPS, down 6.90% or $0.04 from last year’s $-0.58 per share. After $-0.19 actual EPS reported by Concert Pharmaceuticals, Inc. for the previous quarter, Wall Street now forecasts 226.32% negative EPS growth.

Since January 16, 2018, it had 0 insider purchases, and 6 insider sales for $2.60 million activity. On Tuesday, April 17 Cassella James V sold $213,510 worth of Concert Pharmaceuticals, Inc. (NASDAQ:CNCE) or 10,582 shares.

Concert Pharmaceuticals, Inc. (NASDAQ:CNCE) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter:


>